Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2010
12/29/2010EP2267122A1 Controlled dissolution crosslinked protein crystals
12/29/2010EP2267029A2 Methods and compositions for treatment of inflammatory disease using Cadherin-11 modulating agents
12/29/2010EP2267026A1 Albumin fusion proteins
12/29/2010EP2267025A2 Purification of fibrinogen
12/29/2010EP2267024A1 Production of recombinant il-18 binding protein
12/29/2010EP2267023A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267022A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267021A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267020A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
12/29/2010EP2267019A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
12/29/2010EP2267018A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
12/29/2010EP2267017A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
12/29/2010EP2267016A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
12/29/2010EP2267015A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
12/29/2010EP2267014A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267013A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267012A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267011A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267010A2 Activatable recombinant neurotoxins
12/29/2010EP2267009A2 Activatable recombinant neurotoxins
12/29/2010EP2267008A2 Activatable recombinant neurotoxins
12/29/2010EP2267007A1 New gene products of bacillus licheniformis forming or decomposing polyamino acids and associated improved biotechnological production method
12/29/2010EP2267006A1 Enterococcus antigens
12/29/2010EP2267005A1 ADP-ribosylating toxin from Listeria monocytogenes
12/29/2010EP2267004A2 Peptide derived from hepatitis C virus
12/29/2010EP2267002A2 Antimicrobial polypeptides
12/29/2010EP2267001A2 Antimicrobial polypeptides
12/29/2010EP2267000A2 Antimicrobial polypeptides
12/29/2010EP2266618A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266617A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266616A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266615A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266614A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266613A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266612A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266611A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266610A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266609A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266608A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266602A2 Combination approaches for generating immune responses
12/29/2010EP2266595A2 Treatment of infections and other disorders
12/29/2010EP2265719A2 Heat resistant plants and plant tissues and methods and materials for making and using same
12/29/2010EP2265718A1 Methods involving ms4a12 and agents targeting ms4a12 for therapy, diagnosis and testing
12/29/2010EP2265715A2 Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same
12/29/2010EP2265646A1 Reagents and methods for detecting influenza virus proteins
12/29/2010EP2265638A1 Stable cell binding chimeric peptides
12/29/2010EP2265637A1 Targeted identification of immunogenic peptides
12/29/2010EP2265636A1 Mzb1, a novel b cell factor, and uses thereof
12/29/2010EP2265635A1 Modified cpn10 and prr signalling
12/29/2010EP2265634A2 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
12/29/2010EP2265633A2 Antigenic protein fragments of streptococcus pneumoniae
12/29/2010EP2265632A2 Cd4-related polypeptides and methods of use
12/29/2010EP2265284A2 Replication-defective flavivirus vaccines and vaccine vectors
12/29/2010EP2265281A2 Use of interleukin-1 conjugates in the treatment of diabetes
12/29/2010EP2265116A2 Steroidal ligands and their use in gene switch modulation
12/29/2010EP1992638B1 Immunomodulatory and anti-tumour peptides
12/29/2010EP1856153B1 Ykl-40 monoclonal antibodies
12/29/2010EP1778725B1 Polypeptides for oligomeric assembly of antigens
12/29/2010EP1694697B1 Surface-located campylobacter jejuni polypeptides
12/29/2010EP1685405B1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
12/29/2010EP1539228B1 Novel composition and methods for the treatment of immune related diseases
12/29/2010EP1529062B1 Therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
12/29/2010EP1497415B1 Methods for detection or modulation of the interaction of a cytokine receptor with its ligand
12/29/2010EP1496122B1 Novel meloidogyne-resistance gene and utilization thereof
12/29/2010EP1425305B1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
12/29/2010EP1315816B1 Genetically engineered co-expression dna vaccines, construction methods and uses thereof
12/29/2010EP1256625B1 Immortalized vascular adventitial cell line
12/29/2010EP1127069B1 Method of making a monomeric beta-form of a prion protein
12/29/2010EP0781329B2 Overexpression of mammalian and viral proteins
12/29/2010CN201686642U Pre-impregnation device for alcohol washing of soybean protein
12/29/2010CN1995345B Recombinant L-251 protein with anti-inflammatory effect secreted by Japanese lamprey oral gland
12/29/2010CN1948342B HLA-A2 restriction epi polypeptide originated from post selection cancer gene hRabj and its application
12/29/2010CN1934131B Optimized expression of hpv 52 l1 in yeast
12/29/2010CN1856504B Anti-infarction molecules
12/29/2010CN101932712A Maize ethylene signaling genes and modulation of same for improved stress tolerance in plants
12/29/2010CN101932609A Compositions and methods to modulate cell membrane resealing
12/29/2010CN101932601A 胰岛素衍生物 Insulin derivatives
12/29/2010CN101932600A Modified growth hormone polypeptides
12/29/2010CN101932599A Molecule and chimeric molecules thereof
12/29/2010CN101932598A Muteins of tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same
12/29/2010CN101932597A Novel wheat allergens
12/29/2010CN101932595A Phage phi-mru polynucleotides and polypeptides and uses thereof
12/29/2010CN101932594A Self-assembling peptide nanoparticles useful as vaccines
12/29/2010CN101932593A Methods to stabilize proteins and polypeptides
12/29/2010CN101932591A Prevention of disulfide bond reduction during recombinant production of polypeptides
12/29/2010CN101928727A Newcastle disease virus Italien strain auxiliary expression plasmid systems, micro genome for detecting system and application thereof
12/29/2010CN101928723A Preparation of new apolipoprotein A-II
12/29/2010CN101928721A Preparation of new apolipoprotein C-I
12/29/2010CN101928718A Protein trimerization modif and application thereof
12/29/2010CN101928712A Plants having modified growth characteristics and a method for making the same
12/29/2010CN101928711A Chicken interferon-alpha gene by total gene synthesis and protein expression
12/29/2010CN101928710A Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application
12/29/2010CN101928343A Monoclonal antibodies to the CLFA protein and method of use in treating or preventing infections
12/29/2010CN101928342A High-purity menopausal gonadotropin as well as preparation method and application thereof
12/29/2010CN101928341A Purifying process for separating isomers of recombined human interferon alpha1b and detection method thereof
12/29/2010CN101928340A Group of antibacterial peptide derivatives and application thereof
12/29/2010CN101928339A Bambusa affinis 'viridiflavus' aging associated transcription factor, coding gene thereof and use thereof
12/29/2010CN101928338A Cotton GbVe gene, protein coded thereby and use thereof in vegetable verticillium wilt resistance
12/29/2010CN101928337A Chrysanthemum drought-tolerant gene and application thereof
12/29/2010CN101928336A Phosphorus deficiency response regulatory protein and coding gene and application thereof
1 ... 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 ... 2916